Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

AArbutus Biopharma Corp

EconomyAI buildoutMarket MapFundsWatchlist
Log in
A

Arbutus Biopharma Corp

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • News
  • Insider Transactions

Loading earnings…

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • Insider Transactions
YearRevenue YoYGross marginCash & equivalents
YearRevenue YoYGross marginCash & equivalents
(Filed on March 23, 2026)
+128.2%100.0%$18M

An annual SEC report is unavailable for this year.

(Filed on March 23, 2026)
-66.0%100.0%$36.3M
(Filed on March 27, 2025)
-53.5%100.0%$26.3M
(Filed on March 5, 2024)
+255.1%100.0%$30.8M
(Filed on March 2, 2023)
+58.9%100.0%$109.3M
(Filed on March 3, 2022)
+15.0%100.0%$52.3M
(Filed on March 4, 2021)
+1.1%100.0%$31.8M
(Filed on March 5, 2020)
-44.4%100.0%$36.9M
(Filed on March 7, 2019)
+617.6%100.0%$54.3M
(Filed on March 16, 2018)
-93.6%100.0%$23.4M
(Filed on March 16, 2018)
+55.7%100.0%$166.8M
(Filed on March 22, 2017)
-3.3%100.0%$72.2M
(Filed on March 9, 2016)
+9.6%100.0%$68.7M
(Filed on March 13, 2015)
-16.1%100.0%$47.3M
(Filed on March 28, 2014)
-21.3%100.0%$9M
(Filed on March 27, 2013)
+55.4%100.0%$12.3M
(Filed on March 27, 2012)
—100.0%—